- Published at
- by themarketherald.com.au
positive
positive
‘East to West’: AdAlta unveils new strategy to find drug candidates, but appears to’ve ditched AD-214
AdAlta plans to take cell therapy candidates from Southeast Asia, firm them in Aus tests, and then licence products to Europe and America.